EP 1814848 B9 20110302 - 2,3,4-SUBSTITUIERTE CYCLOPENTANONE ALS THERAPEUTISCHE MITTEL
Title (de)
2,3,4-SUBSTITUIERTE CYCLOPENTANONE ALS THERAPEUTISCHE MITTEL
Publication
Application
Priority
- US 2005042428 W 20051121
- US 99703904 A 20041123
Abstract (en)
[origin: US7183324B2] Disclosed herein are compounds comprising or a pharmaceutically acceptable salt or a prodrug thereof; wherein Y, A, B, J, and E are further described. Methods, compositions, and medicaments related thereto are also disclosed.
IPC 8 full level
C07C 405/00 (2006.01); A61K 31/5575 (2006.01); A61P 27/06 (2006.01); C07D 333/16 (2006.01); C07D 333/62 (2006.01)
CPC (source: EP US)
A61P 27/02 (2018.01 - EP); A61P 27/06 (2018.01 - EP); A61P 43/00 (2018.01 - EP); C07C 323/52 (2013.01 - EP US); C07C 405/0033 (2013.01 - EP US); C07D 333/56 (2013.01 - EP US); C07D 333/62 (2013.01 - EP US); C07C 2601/08 (2017.05 - EP US)
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
US 2006111430 A1 20060525; US 7183324 B2 20070227; AT E475643 T1 20100815; AU 2005309605 A1 20060601; AU 2005309605 B2 20120823; BR PI0518299 A2 20081111; CA 2588599 A1 20060601; DE 602005022613 D1 20100909; DK 1814848 T3 20101108; EP 1814848 A1 20070808; EP 1814848 B1 20100728; EP 1814848 B9 20110302; EP 1814848 B9 20111221; ES 2347808 T3 20101104; ES 2347808 T9 20110613; JP 2008520737 A 20080619; JP 5114205 B2 20130109; WO 2006058063 A1 20060601
DOCDB simple family (application)
US 99703904 A 20041123; AT 05852061 T 20051121; AU 2005309605 A 20051121; BR PI0518299 A 20051121; CA 2588599 A 20051121; DE 602005022613 T 20051121; DK 05852061 T 20051121; EP 05852061 A 20051121; ES 05852061 T 20051121; JP 2007543434 A 20051121; US 2005042428 W 20051121